ALICIA SCHERBA: Open Payments
NPI 1811638331 · MOUNTAIN VIEW, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,793 in 159 payments from 18 companies in 2025. Trend: 2023 $3,263 · 2024 $3,516 · 2025 $3,793
Food & beverage: $3,716Education: $77
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 32 | $746 |
| ABBVIE INC. | 24 | $541 |
| Incyte Corporation | 18 | $417 |
| Lilly USA, LLC | 12 | $318 |
| PFIZER INC. | 17 | $311 |
| Galderma Laboratories, L.P. | 6 | $266 |
| Janssen Biotech, Inc. | 10 | $263 |
| Arcutis Biotherapeutics, Inc. | 9 | $209 |
| Regeneron Healthcare Solutions, Inc. | 11 | $195 |
| UCB, Inc. | 5 | $124 |
Products named: ADBRY, OPZELURA, SKYRIZI, TALTZ, CIBINQO, NEMLUVIO, TREMFYA, Zoryve.
Industry payments across CA — which companies pay providers there.
